Commentary/Editorials

Not all hematopoietic growth factors are created equal: should we gain information for their use with immunotherapy?
Paolo Bossi, Cristina Gurizzan, Luigi Lorini, Pierluigi di Mauro, Chiara Sardini, Marco Merlano

Journal for ImmunoTherapy of Cancer Aug 2021, 9 (8) e003154; DOI: 10.1136/jitc-2021-003154
Do the benefits of being a smoker hint at the existence of PD-1/PD-L1 sensitizers for patients on single-agent immunotherapy?
Gintaras Zaleskis, Vita Pasukoniene, Dainius Characiejus, Vincas Urbonas

Journal for ImmunoTherapy of Cancer Aug 2021, 9 (8) e003191; DOI: 10.1136/jitc-2021-003191
Letter to the editor: radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers
Mateus Trinconi Cunha, Vinicius Jardim Carvalho, Rafael Maffei Loureiro, Carlos Eduardo Brantis-de-Carvalho, Murilo Bicudo Cintra, Gilberto de Castro Junior

Journal for ImmunoTherapy of Cancer Jul 2021, 9 (7) e003044; DOI: 10.1136/jitc-2021-003044
Author response to Cunha et al
Rivka R Colen, Christian Rolfo, Murat Ak, Mira Ayoub, Sara Ahmed, Nabil Elshafeey, Priyadarshini Mamindla, Pascal O Zinn, Chaan Ng, Raghu Vikram, Spyridon Bakas, Christine B Peterson, Jordi Rodon Ahnert, Vivek Subbiah, Daniel D Karp, Bettzy Stephen, Joud Hajjar, Aung Naing

Journal for ImmunoTherapy of Cancer Jul 2021, 9 (7) e003299; DOI: 10.1136/jitc-2021-003299
Search for effective treatments in patients with advanced refractory melanoma continues: can novel intratumoral therapies deliver?
Yana G Najjar

Journal for ImmunoTherapy of Cancer Jul 2021, 9 (7) e002820; DOI: 10.1136/jitc-2021-002820
Author response to Colle et al
Giovanni Fucà, Francesca Corti, Filippo Pietrantonio

Journal for ImmunoTherapy of Cancer Jun 2021, 9 (6) e003138; DOI: 10.1136/jitc-2021-003138
Letter to the Editor from Colle et al
Raphael Colle, Thierry Andre, Yves Menu

Journal for ImmunoTherapy of Cancer Jun 2021, 9 (6) e002997; DOI: 10.1136/jitc-2021-002997
Cancer environmental immunotherapy: starving tumor cell to death by targeting TGFB on immune cell
Xing Huang, Gang Zhang, Tingbo Liang

Journal for ImmunoTherapy of Cancer Jun 2021, 9 (6) e002823; DOI: 10.1136/jitc-2021-002823
T follicular helper cells: linking cancer immunotherapy and immune-related adverse events
Dirk Baumjohann, Peter Brossart

Journal for ImmunoTherapy of Cancer Jun 2021, 9 (6) e002588; DOI: 10.1136/jitc-2021-002588
Overlap of immunotherapy-related pneumonitis and COVID-19 pneumonia: diagnostic and vaccine considerations
Muhammad Bilal Abid

Journal for ImmunoTherapy of Cancer Apr 2021, 9 (4) e002307; DOI: 10.1136/jitc-2020-002307

Main menu

Commentary/Editorials

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Commentary/Editorials

Pages